Clinical Trials

Medidata, CRIO Boost Clinical Trials with Integration

Strategic partnership eliminates human error and provides sponsors with real-time, high-quality clinical data for critical eSource-based trials

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has announced a partnership with CRIO, the leading provider of site eSource solutions. The collaboration is driving high data quality standards and efficiencies at over 2,500 research sites across about 30 countries by bridging the gap between clinical site operations and global data management.

This partnership delivers a “plug-and-play” digital pipeline that automates the transfer of clinical data from CRIO eSource directly into the Medidata Platform, which supports the Medidata DataStudy and Patient Experiences, removing the technical complexity and high costs of custom configurations. The collaboration has moved beyond simple connectivity to deliver industry-leading performance benchmarks:

  • Near 100% Data Accuracy: Automated “source-to-EDC” transfer supports data integrity, resulting in a dramatic reduction in queries and data changes
  • 90% Faster Data Entry: Sites can now auto-populate EDC forms with source data, reducing data entry time
  • Broad Market Footprint: One in four US research sites engaged in chronic condition trials now leverage the CRIO-Medidata ecosystem

“Our partnership with CRIO accelerates our strategy connecting site-level eSource and the Medidata Platform,” said Tom Doyle, chief technology officer, Medidata. “This will accelerate workflows for thousands of sites that are often overlooked by traditional integration models, ultimately bringing new therapies to patients faster.”

“For years, clinical sites have been forced to act as manual data bridges between systems, a process that can be time-intensive and prone to error,” said Jonathan Andrus, co-CEO at CRIO. “By integrating CRIO eSource directly with the Medidata Platform, we are eliminating this friction for over 2,500 sites globally, reducing complexity and making clinical research easier for sites.”

GlobeNewswire

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Related posts

Everads Shares Clinical Trial Results at ASRS 2025 Meeting

PR Newswire

Lindus Health Secures ARIA Funding for AI in Clinical Trial Design

PR Newswire

ProofPilot & Citeline Connect releases new data

PR Newswire